2023-2029 Global Targeting p53 Cancer Therapies Industry Research & Trends Analysis Report

Tables and Figures

Table 1. Targeting p53 Cancer Therapies Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Targeting p53 Cancer Therapies Market Restraints
Table 3. Targeting p53 Cancer Therapies Market Trends
Table 4. Targeting p53 Cancer Therapies Industry Policy
Table 5. Global Targeting p53 Cancer Therapies Revenue by Company, 2018-2023, US$ million
Table 6. Global Targeting p53 Cancer Therapies Revenue Market Share by Company, 2018-2023
Table 7. Global Targeting p53 Cancer Therapies Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Targeting p53 Cancer Therapies Sales Volume Market Share by Company, 2018-2023
Table 9. Global Targeting p53 Cancer Therapies Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Targeting p53 Cancer Therapies Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Targeting p53 Cancer Therapies Mergers & Acquisitions, Expansion Plans
Table 12. Global Targeting p53 Cancer Therapies Manufacturers Product Type
Table 13. China Targeting p53 Cancer Therapies Revenue by Company, 2018-2023, US$ million
Table 14. China Targeting p53 Cancer Therapies Revenue Market Share by Company, 2018-2023
Table 15. China Targeting p53 Cancer Therapies Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Targeting p53 Cancer Therapies Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Targeting p53 Cancer Therapies Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Targeting p53 Cancer Therapies Import & Export Trends
Table 19. Main Sources of China Targeting p53 Cancer Therapies Import
Table 20. Export Destination of China Targeting p53 Cancer Therapies
Table 21. Global Headquarters and Manufacturing Base of Targeting p53 Cancer Therapies Manufacturers
Table 22. Global Major Manufacturers, Targeting p53 Cancer Therapies Capacity Expansion and Future Plans
Table 23. Global Targeting p53 Cancer Therapies Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Targeting p53 Cancer Therapies Production by Region, 2018-2023, (K Units)
Table 25. Global Targeting p53 Cancer Therapies Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Targeting p53 Cancer Therapies Upstream (Raw Materials)
Table 27. Global Targeting p53 Cancer Therapies Typical Customers
Table 28. Targeting p53 Cancer Therapies Typical Distributors
Table 29. By Type, Global Targeting p53 Cancer Therapies Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Targeting p53 Cancer Therapies Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Targeting p53 Cancer Therapies Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Targeting p53 Cancer Therapies Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Targeting p53 Cancer Therapies Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Targeting p53 Cancer Therapies Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Targeting p53 Cancer Therapies Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Targeting p53 Cancer Therapies Revenue Market Share, 2018-2029
Table 37. By Country, Global Targeting p53 Cancer Therapies Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Targeting p53 Cancer Therapies Sales Volume Market Share, 2018-2029
Table 39. Sibiono GeneTech Company Information, Head Office, Market Area and Industry Position
Table 40. Sibiono GeneTech Targeting p53 Cancer Therapies Models, Specifications and Application
Table 41. Sibiono GeneTech Targeting p53 Cancer Therapies Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Sibiono GeneTech Company Profile and Main Business
Table 43. Sibiono GeneTech Recent Developments
Table 44. Kartos Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 45. Kartos Therapeutics Targeting p53 Cancer Therapies Models, Specifications and Application
Table 46. Kartos Therapeutics Targeting p53 Cancer Therapies Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Kartos Therapeutics Company Profile and Main Business
Table 48. Kartos Therapeutics Recent Developments
Table 49. SynerGene Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 50. SynerGene Therapeutics Targeting p53 Cancer Therapies Models, Specifications and Application
Table 51. SynerGene Therapeutics Targeting p53 Cancer Therapies Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. SynerGene Therapeutics Company Profile and Main Business
Table 53. SynerGene Therapeutics Recent Developments
Table 54. MultiVir Company Information, Head Office, Market Area and Industry Position
Table 55. MultiVir Targeting p53 Cancer Therapies Models, Specifications and Application
Table 56. MultiVir Targeting p53 Cancer Therapies Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. MultiVir Company Profile and Main Business
Table 58. MultiVir Recent Developments
Table 59. Rain Oncology Company Information, Head Office, Market Area and Industry Position
Table 60. Rain Oncology Targeting p53 Cancer Therapies Models, Specifications and Application
Table 61. Rain Oncology Targeting p53 Cancer Therapies Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Rain Oncology Company Profile and Main Business
Table 63. Rain Oncology Recent Developments
Table 64. Alieron Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 65. Alieron Therapeutics Targeting p53 Cancer Therapies Models, Specifications and Application
Table 66. Alieron Therapeutics Targeting p53 Cancer Therapies Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Alieron Therapeutics Company Profile and Main Business
Table 68. Alieron Therapeutics Recent Developments
Table 69. Aprea Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 70. Aprea Therapeutics Targeting p53 Cancer Therapies Models, Specifications and Application
Table 71. Aprea Therapeutics Targeting p53 Cancer Therapies Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Aprea Therapeutics Company Profile and Main Business
Table 73. Aprea Therapeutics Recent Developments
Table 74. Ascentage Pharma Company Information, Head Office, Market Area and Industry Position
Table 75. Ascentage Pharma Targeting p53 Cancer Therapies Models, Specifications and Application
Table 76. Ascentage Pharma Targeting p53 Cancer Therapies Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Ascentage Pharma Company Profile and Main Business
Table 78. Ascentage Pharma Recent Developments
Table 79. Jc (Wuxi) Company Company Information, Head Office, Market Area and Industry Position
Table 80. Jc (Wuxi) Company Targeting p53 Cancer Therapies Models, Specifications and Application
Table 81. Jc (Wuxi) Company Targeting p53 Cancer Therapies Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Jc (Wuxi) Company Company Profile and Main Business
Table 83. Jc (Wuxi) Company Recent Developments
List of Figure
Figure 1. Targeting p53 Cancer Therapies Picture
Figure 2. By Revenue, Global Targeting p53 Cancer Therapies Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Targeting p53 Cancer Therapies Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Targeting p53 Cancer Therapies Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Targeting p53 Cancer Therapies Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Targeting p53 Cancer Therapies Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Targeting p53 Cancer Therapies Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Targeting p53 Cancer Therapies Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Targeting p53 Cancer Therapies Share of Global Market, 2018-2029
Figure 10. Global Targeting p53 Cancer Therapies Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Targeting p53 Cancer Therapies Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Targeting p53 Cancer Therapies Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Targeting p53 Cancer Therapies Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Targeting p53 Cancer Therapies Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Targeting p53 Cancer Therapies Domestic VS Export, 2022
Figure 16. Global Targeting p53 Cancer Therapies Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Targeting p53 Cancer Therapies Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Targeting p53 Cancer Therapies Production Market Share & Forecast by Region, 2018-2029
Figure 19. Targeting p53 Cancer Therapies Industry Chain
Figure 20. Targeting p53 Cancer Therapies Procurement Model
Figure 21. Targeting p53 Cancer Therapies Sales Model
Figure 22. Targeting p53 Cancer Therapies Sales Channels, Direct Sales and Distribution
Figure 23. Small Molecule Drugs
Figure 24. Immunotherapy
Figure 25. Gene Therapy
Figure 26. Others
Figure 27. By Type, Global Targeting p53 Cancer Therapies Revenue, 2018-2029, US$ Million
Figure 28. By Type, Global Targeting p53 Cancer Therapies Revenue Market Share, 2018-2029
Figure 29. By Type, Global Targeting p53 Cancer Therapies Sales Volume, 2018-2029, (K Units)
Figure 30. By Type, Global Targeting p53 Cancer Therapies Sales Volume Market Share, 2018-2029
Figure 31. By Type, Global Targeting p53 Cancer Therapies Price, 2018-2029, (US$/Unit)
Figure 32. Hospital
Figure 33. Clinic
Figure 34. Others
Figure 35. By Application, Global Targeting p53 Cancer Therapies Revenue, 2018-2029, US$ Million
Figure 36. By Application, Global Targeting p53 Cancer Therapies Revenue Market Share, 2018-2029
Figure 37. By Application, Global Targeting p53 Cancer Therapies Sales Volume, 2018-2029, (K Units)
Figure 38. By Application, Global Targeting p53 Cancer Therapies Sales Volume Market Share, 2018-2029
Figure 39. By Application, Global Targeting p53 Cancer Therapies Price, 2018-2029, (US$/Unit)
Figure 40. By Region, Global Targeting p53 Cancer Therapies Revenue Market Share, 2018-2029
Figure 41. By Region, Global Targeting p53 Cancer Therapies Sales Volume Market Share, 2018-2029
Figure 42. North America Targeting p53 Cancer Therapies Revenue & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, North America Targeting p53 Cancer Therapies Revenue Market Share, 2022
Figure 44. Europe Targeting p53 Cancer Therapies Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, Europe Targeting p53 Cancer Therapies Revenue Market Share, 2022
Figure 46. Asia Pacific Targeting p53 Cancer Therapies Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country/Region, Asia Pacific Targeting p53 Cancer Therapies Revenue Market Share, 2022
Figure 48. South America Targeting p53 Cancer Therapies Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. By Country, South America Targeting p53 Cancer Therapies Revenue Market Share, 2022
Figure 50. Middle East & Africa Targeting p53 Cancer Therapies Revenue & Forecasts, 2018-2029, US$ Million
Figure 51. U.S. Targeting p53 Cancer Therapies Sales Volume, 2018-2029, (K Units)
Figure 52. By Company, U.S. Targeting p53 Cancer Therapies Market Share, 2022
Figure 53. By Type, U.S. Targeting p53 Cancer Therapies Sales Volume Market Share, 2022 VS 2029
Figure 54. By Application, U.S. Targeting p53 Cancer Therapies Sales Volume Market Share, 2022 VS 2029
Figure 55. Europe Targeting p53 Cancer Therapies Sales Volume, 2018-2029, (K Units)
Figure 56. By Company, Europe Targeting p53 Cancer Therapies Market Share, 2022
Figure 57. By Type, Europe Targeting p53 Cancer Therapies Sales Volume Market Share, 2022 VS 2029
Figure 58. By Application, Europe Targeting p53 Cancer Therapies Sales Volume Market Share, 2022 VS 2029
Figure 59. China Targeting p53 Cancer Therapies Sales Volume, 2018-2029, (K Units)
Figure 60. By Company, China Targeting p53 Cancer Therapies Market Share, 2022
Figure 61. By Type, China Targeting p53 Cancer Therapies Sales Volume Market Share, 2022 VS 2029
Figure 62. By Application, China Targeting p53 Cancer Therapies Sales Volume Market Share, 2022 VS 2029
Figure 63. Japan Targeting p53 Cancer Therapies Sales Volume, 2018-2029, (K Units)
Figure 64. By Company, Japan Targeting p53 Cancer Therapies Market Share, 2022
Figure 65. By Type, Japan Targeting p53 Cancer Therapies Sales Volume Market Share, 2022 VS 2029
Figure 66. By Application, Japan Targeting p53 Cancer Therapies Sales Volume Market Share, 2022 VS 2029
Figure 67. South Korea Targeting p53 Cancer Therapies Sales Volume, 2018-2029, (K Units)
Figure 68. By Company, South Korea Targeting p53 Cancer Therapies Market Share, 2022
Figure 69. By Type, South Korea Targeting p53 Cancer Therapies Sales Volume Market Share, 2022 VS 2029
Figure 70. By Application, South Korea Targeting p53 Cancer Therapies Sales Volume Market Share, 2022 VS 2029
Figure 71. Southeast Asia Targeting p53 Cancer Therapies Sales Volume, 2018-2029, (K Units)
Figure 72. By Company, Southeast Asia Targeting p53 Cancer Therapies Market Share, 2022
Figure 73. By Type, Southeast Asia Targeting p53 Cancer Therapies Sales Volume Market Share, 2022 VS 2029
Figure 74. By Application, Southeast Asia Targeting p53 Cancer Therapies Sales Volume Market Share, 2022 VS 2029
Figure 75. India Targeting p53 Cancer Therapies Sales Volume, 2018-2029, (K Units)
Figure 76. By Company, India Targeting p53 Cancer Therapies Market Share, 2022
Figure 77. By Type, India Targeting p53 Cancer Therapies Sales Volume Market Share, 2022 VS 2029
Figure 78. By Application, India Targeting p53 Cancer Therapies Sales Volume Market Share, 2022 VS 2029
Figure 79. Middle East & Asia Targeting p53 Cancer Therapies Sales Volume, 2018-2029, (K Units)
Figure 80. By Company, Middle East & Asia Targeting p53 Cancer Therapies Market Share, 2022
Figure 81. By Type, Middle East & Asia Targeting p53 Cancer Therapies Sales Volume Market Share, 2022 VS 2029
Figure 82. By Application, Middle East & Asia Targeting p53 Cancer Therapies Sales Volume Market Share, 2022 VS 2029
Figure 83. Research Methodology
Figure 84. Breakdown of Primary Interviews
Figure 85. Bottom-up Approaches
Figure 86. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets